nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—MAP2K5—restless legs syndrome	0.774	1	CbGaD
Bosutinib—Vandetanib—MAP2K5—restless legs syndrome	0.00391	0.513	CrCbGaD
Bosutinib—Gefitinib—MAP2K5—restless legs syndrome	0.00372	0.487	CrCbGaD
Bosutinib—SIK1—Circadian rythm related genes—BTBD9—restless legs syndrome	0.00316	0.0371	CbGpPWpGaD
Bosutinib—LOC400927-CSNK1E—Circadian rythm related genes—BTBD9—restless legs syndrome	0.00258	0.0302	CbGpPWpGaD
Bosutinib—ALK—Differentiation Pathway—TF—restless legs syndrome	0.00248	0.0292	CbGpPWpGaD
Bosutinib—MAP3K2—Trk receptor signaling mediated by the MAPK pathway—MAP2K5—restless legs syndrome	0.00227	0.0266	CbGpPWpGaD
Bosutinib—IKBKE—Cardiac Hypertrophic Response—MAP2K5—restless legs syndrome	0.00186	0.0219	CbGpPWpGaD
Bosutinib—MAP4K4—EPHB forward signaling—TF—restless legs syndrome	0.00161	0.0189	CbGpPWpGaD
Bosutinib—MAP4K1—Cardiac Hypertrophic Response—MAP2K5—restless legs syndrome	0.00154	0.0181	CbGpPWpGaD
Bosutinib—EPHB3—EPHB forward signaling—TF—restless legs syndrome	0.00143	0.0168	CbGpPWpGaD
Bosutinib—CSNK1E—Circadian rythm related genes—BTBD9—restless legs syndrome	0.00135	0.0159	CbGpPWpGaD
Bosutinib—IKBKE—MicroRNAs in cardiomyocyte hypertrophy—MAP2K5—restless legs syndrome	0.00133	0.0156	CbGpPWpGaD
Bosutinib—MAP4K2—Insulin Signaling—MAP2K5—restless legs syndrome	0.00128	0.0151	CbGpPWpGaD
Bosutinib—STK3—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.00123	0.0145	CbGpPWpGaD
Bosutinib—MAP4K5—Insulin Signaling—MAP2K5—restless legs syndrome	0.00123	0.0144	CbGpPWpGaD
Bosutinib—EPHB4—EPHB forward signaling—TF—restless legs syndrome	0.00122	0.0143	CbGpPWpGaD
Bosutinib—CASK—Syndecan-3-mediated signaling events—POMC—restless legs syndrome	0.00121	0.0143	CbGpPWpGaD
Bosutinib—EPHB2—EPHB forward signaling—TF—restless legs syndrome	0.00118	0.0138	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.00116	0.0136	CbGpPWpGaD
Bosutinib—MAP3K12—Insulin Signaling—MAP2K5—restless legs syndrome	0.00114	0.0134	CbGpPWpGaD
Bosutinib—MAP3K12—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.0011	0.0129	CbGpPWpGaD
Bosutinib—LRRK2—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.0011	0.0129	CbGpPWpGaD
Bosutinib—SRMS—Focal Adhesion—MAP2K5—restless legs syndrome	0.00107	0.0126	CbGpPWpGaD
Bosutinib—TNK2—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.00101	0.0118	CbGpPWpGaD
Bosutinib—CDK2—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000987	0.0116	CbGpPWpGaD
Bosutinib—MAP4K4—Insulin Signaling—MAP2K5—restless legs syndrome	0.000973	0.0114	CbGpPWpGaD
Bosutinib—CSK—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.000957	0.0112	CbGpPWpGaD
Bosutinib—MAP4K4—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000935	0.011	CbGpPWpGaD
Bosutinib—MAP2K1—Trk receptor signaling mediated by the MAPK pathway—MAP2K5—restless legs syndrome	0.000927	0.0109	CbGpPWpGaD
Bosutinib—MAP3K2—ErbB1 downstream signaling—MAP2K5—restless legs syndrome	0.00092	0.0108	CbGpPWpGaD
Bosutinib—CSF1R—Differentiation Pathway—TF—restless legs syndrome	0.000919	0.0108	CbGpPWpGaD
Bosutinib—TXK—Focal Adhesion—MAP2K5—restless legs syndrome	0.000912	0.0107	CbGpPWpGaD
Bosutinib—TNK2—Focal Adhesion—MAP2K5—restless legs syndrome	0.000889	0.0104	CbGpPWpGaD
Bosutinib—MAP3K7—Cardiac Hypertrophic Response—MAP2K5—restless legs syndrome	0.000771	0.00905	CbGpPWpGaD
Bosutinib—ROCK1—MicroRNAs in cardiomyocyte hypertrophy—MAP2K5—restless legs syndrome	0.000755	0.00886	CbGpPWpGaD
Bosutinib—ROCK1—EPHB forward signaling—TF—restless legs syndrome	0.000745	0.00874	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000715	0.00839	CbGpPWpGaD
Bosutinib—MAP3K2—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000715	0.00839	CbGpPWpGaD
Bosutinib—PRKCQ—Insulin Signaling—MAP2K5—restless legs syndrome	0.00068	0.00799	CbGpPWpGaD
Bosutinib—MAP2K2—Cardiac Hypertrophic Response—MAP2K5—restless legs syndrome	0.000674	0.00791	CbGpPWpGaD
Bosutinib—MAP4K1—Insulin Signaling—MAP2K5—restless legs syndrome	0.000657	0.00771	CbGpPWpGaD
Bosutinib—MAP3K2—Insulin Signaling—MAP2K5—restless legs syndrome	0.000657	0.00771	CbGpPWpGaD
Bosutinib—ROCK1—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.000657	0.00771	CbGpPWpGaD
Bosutinib—MAP4K1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.00065	0.00764	CbGpPWpGaD
Bosutinib—MAP3K2—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.00065	0.00764	CbGpPWpGaD
Bosutinib—CSK—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.00065	0.00764	CbGpPWpGaD
Bosutinib—MAP4K1—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000632	0.00742	CbGpPWpGaD
Bosutinib—MAP3K2—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000632	0.00742	CbGpPWpGaD
Bosutinib—MAP2K1—Cardiac Hypertrophic Response—MAP2K5—restless legs syndrome	0.000631	0.0074	CbGpPWpGaD
Bosutinib—PTK2—EPHB forward signaling—TF—restless legs syndrome	0.000616	0.00723	CbGpPWpGaD
Bosutinib—FYN—Ectoderm Differentiation—TOX3—restless legs syndrome	0.000578	0.00679	CbGpPWpGaD
Bosutinib—MAP3K3—Insulin Signaling—MAP2K5—restless legs syndrome	0.000565	0.00663	CbGpPWpGaD
Bosutinib—MAP3K3—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000559	0.00657	CbGpPWpGaD
Bosutinib—PTK2—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.000543	0.00637	CbGpPWpGaD
Bosutinib—PTK2B—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000509	0.00598	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.00049	0.00575	CbGpPWpGaD
Bosutinib—PRKCQ—brain—restless legs syndrome	0.000486	0.00364	CbGeAlD
Bosutinib—MAP2K2—MicroRNAs in cardiomyocyte hypertrophy—MAP2K5—restless legs syndrome	0.00048	0.00564	CbGpPWpGaD
Bosutinib—ERBB4—spinal cord—restless legs syndrome	0.00048	0.0036	CbGeAlD
Bosutinib—STK33—brain—restless legs syndrome	0.000479	0.00359	CbGeAlD
Bosutinib—SIK2—brain—restless legs syndrome	0.000479	0.00359	CbGeAlD
Bosutinib—PLK2—nervous system—restless legs syndrome	0.000478	0.00359	CbGeAlD
Bosutinib—PDGFRB—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000478	0.00561	CbGpPWpGaD
Bosutinib—SIK3—nervous system—restless legs syndrome	0.000475	0.00356	CbGeAlD
Bosutinib—STK25—central nervous system—restless legs syndrome	0.000474	0.00355	CbGeAlD
Bosutinib—RPS6KB1—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000473	0.00555	CbGpPWpGaD
Bosutinib—EPHA3—central nervous system—restless legs syndrome	0.00047	0.00353	CbGeAlD
Bosutinib—TAOK3—brainstem—restless legs syndrome	0.000467	0.0035	CbGeAlD
Bosutinib—PKMYT1—brain—restless legs syndrome	0.000467	0.0035	CbGeAlD
Bosutinib—PTK2B—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000463	0.00544	CbGpPWpGaD
Bosutinib—PLK2—central nervous system—restless legs syndrome	0.000461	0.00345	CbGeAlD
Bosutinib—MAP2K1—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000458	0.00538	CbGpPWpGaD
Bosutinib—SIK3—central nervous system—restless legs syndrome	0.000458	0.00343	CbGeAlD
Bosutinib—STK4—nervous system—restless legs syndrome	0.000457	0.00343	CbGeAlD
Bosutinib—EPHB3—spinal cord—restless legs syndrome	0.000456	0.00342	CbGeAlD
Bosutinib—CLK3—brain—restless legs syndrome	0.000456	0.00342	CbGeAlD
Bosutinib—DSTYK—brain—restless legs syndrome	0.000456	0.00342	CbGeAlD
Bosutinib—CAMK1D—nervous system—restless legs syndrome	0.000452	0.00339	CbGeAlD
Bosutinib—HIPK4—brain—restless legs syndrome	0.000451	0.00338	CbGeAlD
Bosutinib—MAP2K1—MicroRNAs in cardiomyocyte hypertrophy—MAP2K5—restless legs syndrome	0.000449	0.00528	CbGpPWpGaD
Bosutinib—STK24—nervous system—restless legs syndrome	0.000447	0.00335	CbGeAlD
Bosutinib—ROCK1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000446	0.00524	CbGpPWpGaD
Bosutinib—PHKG1—brain—restless legs syndrome	0.000446	0.00334	CbGeAlD
Bosutinib—EPHB2—brain—restless legs syndrome	0.000446	0.00334	CbGeAlD
Bosutinib—CASK—brain—restless legs syndrome	0.000446	0.00334	CbGeAlD
Bosutinib—MAP2K1—EPHB forward signaling—TF—restless legs syndrome	0.000443	0.0052	CbGpPWpGaD
Bosutinib—MAP4K4—spinal cord—restless legs syndrome	0.000443	0.00332	CbGeAlD
Bosutinib—EIF2AK1—brain—restless legs syndrome	0.000441	0.0033	CbGeAlD
Bosutinib—STK4—central nervous system—restless legs syndrome	0.00044	0.0033	CbGeAlD
Bosutinib—HCK—Focal Adhesion—MAP2K5—restless legs syndrome	0.000439	0.00516	CbGpPWpGaD
Bosutinib—BCR—spinal cord—restless legs syndrome	0.000439	0.00329	CbGeAlD
Bosutinib—MAP3K12—spinal cord—restless legs syndrome	0.000436	0.00327	CbGeAlD
Bosutinib—SRMS—brain—restless legs syndrome	0.000436	0.00327	CbGeAlD
Bosutinib—CAMK1D—central nervous system—restless legs syndrome	0.000435	0.00326	CbGeAlD
Bosutinib—RPS6KB1—Insulin Signaling—MAP2K5—restless legs syndrome	0.000434	0.0051	CbGpPWpGaD
Bosutinib—FER—nervous system—restless legs syndrome	0.000432	0.00324	CbGeAlD
Bosutinib—ALK—nervous system—restless legs syndrome	0.000432	0.00324	CbGeAlD
Bosutinib—EPHA5—nervous system—restless legs syndrome	0.000432	0.00324	CbGeAlD
Bosutinib—TYRO3—nervous system—restless legs syndrome	0.000432	0.00324	CbGeAlD
Bosutinib—STK24—central nervous system—restless legs syndrome	0.00043	0.00323	CbGeAlD
Bosutinib—RPS6KB1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.00043	0.00505	CbGpPWpGaD
Bosutinib—LYN—nervous system—restless legs syndrome	0.00043	0.00322	CbGeAlD
Bosutinib—MAP2K1—spinal cord—restless legs syndrome	0.000427	0.0032	CbGeAlD
Bosutinib—VRK2—brain—restless legs syndrome	0.000427	0.0032	CbGeAlD
Bosutinib—FES—brain—restless legs syndrome	0.000427	0.0032	CbGeAlD
Bosutinib—EPHA8—brain—restless legs syndrome	0.000427	0.0032	CbGeAlD
Bosutinib—CSK—spinal cord—restless legs syndrome	0.000425	0.00318	CbGeAlD
Bosutinib—MAP3K19—nervous system—restless legs syndrome	0.000424	0.00318	CbGeAlD
Bosutinib—CSNK1A1—spinal cord—restless legs syndrome	0.000422	0.00316	CbGeAlD
Bosutinib—HCK—spinal cord—restless legs syndrome	0.000419	0.00314	CbGeAlD
Bosutinib—CLK1—spinal cord—restless legs syndrome	0.000419	0.00314	CbGeAlD
Bosutinib—SYK—brain—restless legs syndrome	0.000419	0.00314	CbGeAlD
Bosutinib—TNIK—brain—restless legs syndrome	0.000419	0.00314	CbGeAlD
Bosutinib—MAP2K5—brainstem—restless legs syndrome	0.000419	0.00314	CbGeAlD
Bosutinib—MAP2K2—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.000418	0.0049	CbGpPWpGaD
Bosutinib—EPHA5—central nervous system—restless legs syndrome	0.000416	0.00312	CbGeAlD
Bosutinib—TYRO3—central nervous system—restless legs syndrome	0.000416	0.00312	CbGeAlD
Bosutinib—ALK—central nervous system—restless legs syndrome	0.000416	0.00312	CbGeAlD
Bosutinib—FER—central nervous system—restless legs syndrome	0.000416	0.00312	CbGeAlD
Bosutinib—TNK2—nervous system—restless legs syndrome	0.000415	0.00311	CbGeAlD
Bosutinib—CDK2—brain—restless legs syndrome	0.000415	0.00311	CbGeAlD
Bosutinib—LYN—central nervous system—restless legs syndrome	0.000414	0.0031	CbGeAlD
Bosutinib—CAMK2G—spinal cord—restless legs syndrome	0.000411	0.00308	CbGeAlD
Bosutinib—BMP2K—spinal cord—restless legs syndrome	0.000411	0.00308	CbGeAlD
Bosutinib—STK26—brain—restless legs syndrome	0.000411	0.00308	CbGeAlD
Bosutinib—MAP3K19—central nervous system—restless legs syndrome	0.000408	0.00306	CbGeAlD
Bosutinib—LRRK2—spinal cord—restless legs syndrome	0.000408	0.00306	CbGeAlD
Bosutinib—ERBB4—nervous system—restless legs syndrome	0.000404	0.00303	CbGeAlD
Bosutinib—MAP2K2—ErbB1 downstream signaling—MAP2K5—restless legs syndrome	0.000402	0.00472	CbGpPWpGaD
Bosutinib—TNK2—central nervous system—restless legs syndrome	0.0004	0.003	CbGeAlD
Bosutinib—ROCK1—nervous system—restless legs syndrome	0.000399	0.00299	CbGeAlD
Bosutinib—BLK—Focal Adhesion—MAP2K5—restless legs syndrome	0.000398	0.00467	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000398	0.00467	CbGpPWpGaD
Bosutinib—CHEK2—brain—restless legs syndrome	0.000397	0.00298	CbGeAlD
Bosutinib—FGR—Focal Adhesion—MAP2K5—restless legs syndrome	0.000397	0.00466	CbGpPWpGaD
Bosutinib—DMPK—brain—restless legs syndrome	0.000394	0.00295	CbGeAlD
Bosutinib—WEE1—brain—restless legs syndrome	0.000394	0.00295	CbGeAlD
Bosutinib—FYN—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.000393	0.00461	CbGpPWpGaD
Bosutinib—ROCK1—Focal Adhesion—MAP2K5—restless legs syndrome	0.000393	0.00461	CbGpPWpGaD
Bosutinib—CSNK1E—spinal cord—restless legs syndrome	0.000391	0.00293	CbGeAlD
Bosutinib—MAP2K1—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.000391	0.00459	CbGpPWpGaD
Bosutinib—ERBB4—central nervous system—restless legs syndrome	0.000389	0.00292	CbGeAlD
Bosutinib—ERBB4—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000388	0.00456	CbGpPWpGaD
Bosutinib—BMPR2—nervous system—restless legs syndrome	0.000387	0.0029	CbGeAlD
Bosutinib—SIK1—spinal cord—restless legs syndrome	0.000385	0.00289	CbGeAlD
Bosutinib—IRAK4—spinal cord—restless legs syndrome	0.000385	0.00289	CbGeAlD
Bosutinib—STK36—nervous system—restless legs syndrome	0.000384	0.00288	CbGeAlD
Bosutinib—EPHB3—nervous system—restless legs syndrome	0.000384	0.00288	CbGeAlD
Bosutinib—ROCK1—central nervous system—restless legs syndrome	0.000384	0.00288	CbGeAlD
Bosutinib—MERTK—nervous system—restless legs syndrome	0.00038	0.00285	CbGeAlD
Bosutinib—ERBB3—spinal cord—restless legs syndrome	0.000377	0.00283	CbGeAlD
Bosutinib—MAP2K2—spinal cord—restless legs syndrome	0.000376	0.00282	CbGeAlD
Bosutinib—ULK3—spinal cord—restless legs syndrome	0.000376	0.00282	CbGeAlD
Bosutinib—STK25—brain—restless legs syndrome	0.000376	0.00282	CbGeAlD
Bosutinib—MAP2K1—ErbB1 downstream signaling—MAP2K5—restless legs syndrome	0.000376	0.00441	CbGpPWpGaD
Bosutinib—EPHA3—brain—restless legs syndrome	0.000373	0.0028	CbGeAlD
Bosutinib—BMPR2—central nervous system—restless legs syndrome	0.000373	0.0028	CbGeAlD
Bosutinib—MAP4K4—nervous system—restless legs syndrome	0.000373	0.0028	CbGeAlD
Bosutinib—BCR—nervous system—restless legs syndrome	0.00037	0.00278	CbGeAlD
Bosutinib—MAP3K7—spinal cord—restless legs syndrome	0.00037	0.00277	CbGeAlD
Bosutinib—STK36—central nervous system—restless legs syndrome	0.00037	0.00277	CbGeAlD
Bosutinib—EPHB3—central nervous system—restless legs syndrome	0.00037	0.00277	CbGeAlD
Bosutinib—PTK2—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000369	0.00433	CbGpPWpGaD
Bosutinib—MAP3K12—nervous system—restless legs syndrome	0.000368	0.00276	CbGeAlD
Bosutinib—PTK2—spinal cord—restless legs syndrome	0.000366	0.00274	CbGeAlD
Bosutinib—TBK1—spinal cord—restless legs syndrome	0.000366	0.00274	CbGeAlD
Bosutinib—MERTK—central nervous system—restless legs syndrome	0.000366	0.00274	CbGeAlD
Bosutinib—PLK2—brain—restless legs syndrome	0.000366	0.00274	CbGeAlD
Bosutinib—SIK3—brain—restless legs syndrome	0.000363	0.00272	CbGeAlD
Bosutinib—MAP2K1—nervous system—restless legs syndrome	0.00036	0.0027	CbGeAlD
Bosutinib—STK35—nervous system—restless legs syndrome	0.00036	0.0027	CbGeAlD
Bosutinib—MAP4K4—central nervous system—restless legs syndrome	0.000359	0.00269	CbGeAlD
Bosutinib—CSK—nervous system—restless legs syndrome	0.000358	0.00268	CbGeAlD
Bosutinib—BCR—central nervous system—restless legs syndrome	0.000356	0.00267	CbGeAlD
Bosutinib—CSNK1A1—nervous system—restless legs syndrome	0.000355	0.00267	CbGeAlD
Bosutinib—MAP3K12—central nervous system—restless legs syndrome	0.000354	0.00265	CbGeAlD
Bosutinib—HCK—nervous system—restless legs syndrome	0.000353	0.00265	CbGeAlD
Bosutinib—CLK1—nervous system—restless legs syndrome	0.000353	0.00265	CbGeAlD
Bosutinib—RPS6KB1—spinal cord—restless legs syndrome	0.000352	0.00264	CbGeAlD
Bosutinib—STK4—brain—restless legs syndrome	0.00035	0.00262	CbGeAlD
Bosutinib—AXL—spinal cord—restless legs syndrome	0.000348	0.00261	CbGeAlD
Bosutinib—MAP2K1—central nervous system—restless legs syndrome	0.000347	0.0026	CbGeAlD
Bosutinib—STK35—central nervous system—restless legs syndrome	0.000347	0.0026	CbGeAlD
Bosutinib—CAMK2G—nervous system—restless legs syndrome	0.000347	0.0026	CbGeAlD
Bosutinib—BMP2K—nervous system—restless legs syndrome	0.000347	0.0026	CbGeAlD
Bosutinib—CAMK1D—brain—restless legs syndrome	0.000345	0.00259	CbGeAlD
Bosutinib—CSK—central nervous system—restless legs syndrome	0.000344	0.00258	CbGeAlD
Bosutinib—LRRK2—nervous system—restless legs syndrome	0.000344	0.00258	CbGeAlD
Bosutinib—CSNK1A1—central nervous system—restless legs syndrome	0.000342	0.00257	CbGeAlD
Bosutinib—ERBB3—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000342	0.00402	CbGpPWpGaD
Bosutinib—STK24—brain—restless legs syndrome	0.000342	0.00256	CbGeAlD
Bosutinib—HCK—central nervous system—restless legs syndrome	0.00034	0.00255	CbGeAlD
Bosutinib—CLK1—central nervous system—restless legs syndrome	0.00034	0.00255	CbGeAlD
Bosutinib—SRC—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000339	0.00399	CbGpPWpGaD
Bosutinib—FYN—Syndecan-3-mediated signaling events—POMC—restless legs syndrome	0.000337	0.00395	CbGpPWpGaD
Bosutinib—SLK—spinal cord—restless legs syndrome	0.000335	0.00251	CbGeAlD
Bosutinib—PTK2B—nervous system—restless legs syndrome	0.000335	0.00251	CbGeAlD
Bosutinib—CAMK2G—central nervous system—restless legs syndrome	0.000334	0.0025	CbGeAlD
Bosutinib—BMP2K—central nervous system—restless legs syndrome	0.000334	0.0025	CbGeAlD
Bosutinib—EPHB4—spinal cord—restless legs syndrome	0.000333	0.0025	CbGeAlD
Bosutinib—LRRK2—central nervous system—restless legs syndrome	0.000331	0.00248	CbGeAlD
Bosutinib—TYRO3—brain—restless legs syndrome	0.00033	0.00248	CbGeAlD
Bosutinib—EPHA5—brain—restless legs syndrome	0.00033	0.00248	CbGeAlD
Bosutinib—ALK—brain—restless legs syndrome	0.00033	0.00248	CbGeAlD
Bosutinib—FER—brain—restless legs syndrome	0.00033	0.00248	CbGeAlD
Bosutinib—CSNK1E—nervous system—restless legs syndrome	0.000329	0.00247	CbGeAlD
Bosutinib—LYN—brain—restless legs syndrome	0.000329	0.00246	CbGeAlD
Bosutinib—SRC—EPHB forward signaling—TF—restless legs syndrome	0.000329	0.00386	CbGpPWpGaD
Bosutinib—MAP3K7—Insulin Signaling—MAP2K5—restless legs syndrome	0.000328	0.00385	CbGpPWpGaD
Bosutinib—EGFR—ErbB1 downstream signaling—MAP2K5—restless legs syndrome	0.000327	0.00383	CbGpPWpGaD
Bosutinib—FYN—spinal cord—restless legs syndrome	0.000326	0.00245	CbGeAlD
Bosutinib—PTK2—Focal Adhesion—MAP2K5—restless legs syndrome	0.000325	0.00381	CbGpPWpGaD
Bosutinib—SIK1—nervous system—restless legs syndrome	0.000324	0.00243	CbGeAlD
Bosutinib—IRAK4—nervous system—restless legs syndrome	0.000324	0.00243	CbGeAlD
Bosutinib—MAP4K1—brain—restless legs syndrome	0.000324	0.00243	CbGeAlD
Bosutinib—MAP3K19—brain—restless legs syndrome	0.000324	0.00243	CbGeAlD
Bosutinib—ABL1—brainstem—restless legs syndrome	0.000323	0.00242	CbGeAlD
Bosutinib—PTK2B—central nervous system—restless legs syndrome	0.000322	0.00242	CbGeAlD
Bosutinib—BTK—brain—restless legs syndrome	0.000322	0.00242	CbGeAlD
Bosutinib—EPHA4—nervous system—restless legs syndrome	0.000321	0.00241	CbGeAlD
Bosutinib—MERTK—Hemostasis—TF—restless legs syndrome	0.000321	0.00377	CbGpPWpGaD
Bosutinib—MAP3K3—spinal cord—restless legs syndrome	0.000319	0.00239	CbGeAlD
Bosutinib—MAP4K5—spinal cord—restless legs syndrome	0.000319	0.00239	CbGeAlD
Bosutinib—ERBB3—nervous system—restless legs syndrome	0.000318	0.00238	CbGeAlD
Bosutinib—TNK2—brain—restless legs syndrome	0.000317	0.00238	CbGeAlD
Bosutinib—CSNK1E—central nervous system—restless legs syndrome	0.000317	0.00238	CbGeAlD
Bosutinib—MAP2K2—nervous system—restless legs syndrome	0.000317	0.00238	CbGeAlD
Bosutinib—ULK3—nervous system—restless legs syndrome	0.000317	0.00238	CbGeAlD
Bosutinib—MAP3K7—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000316	0.00371	CbGpPWpGaD
Bosutinib—MAP3K2—nervous system—restless legs syndrome	0.000315	0.00236	CbGeAlD
Bosutinib—MAP4K2—brain—restless legs syndrome	0.000313	0.00235	CbGeAlD
Bosutinib—IRAK4—central nervous system—restless legs syndrome	0.000312	0.00234	CbGeAlD
Bosutinib—SIK1—central nervous system—restless legs syndrome	0.000312	0.00234	CbGeAlD
Bosutinib—MAP2K2—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000312	0.00366	CbGpPWpGaD
Bosutinib—EPHA4—central nervous system—restless legs syndrome	0.000309	0.00232	CbGeAlD
Bosutinib—STK3—brain—restless legs syndrome	0.000309	0.00232	CbGeAlD
Bosutinib—ERBB4—brain—restless legs syndrome	0.000309	0.00232	CbGeAlD
Bosutinib—TBK1—nervous system—restless legs syndrome	0.000308	0.00231	CbGeAlD
Bosutinib—PTK2—nervous system—restless legs syndrome	0.000308	0.00231	CbGeAlD
Bosutinib—ERBB3—central nervous system—restless legs syndrome	0.000306	0.00229	CbGeAlD
Bosutinib—ULK3—central nervous system—restless legs syndrome	0.000305	0.00229	CbGeAlD
Bosutinib—MAP2K2—central nervous system—restless legs syndrome	0.000305	0.00229	CbGeAlD
Bosutinib—ROCK1—brain—restless legs syndrome	0.000305	0.00229	CbGeAlD
Bosutinib—MAP3K2—central nervous system—restless legs syndrome	0.000303	0.00227	CbGeAlD
Bosutinib—ERBB4—Signaling by NGF—MAP2K5—restless legs syndrome	0.000298	0.0035	CbGpPWpGaD
Bosutinib—TBK1—central nervous system—restless legs syndrome	0.000297	0.00223	CbGeAlD
Bosutinib—PTK2—central nervous system—restless legs syndrome	0.000297	0.00223	CbGeAlD
Bosutinib—RPS6KB1—nervous system—restless legs syndrome	0.000297	0.00222	CbGeAlD
Bosutinib—BMPR2—brain—restless legs syndrome	0.000296	0.00222	CbGeAlD
Bosutinib—FGR—nervous system—restless legs syndrome	0.000295	0.00221	CbGeAlD
Bosutinib—YES1—spinal cord—restless legs syndrome	0.000294	0.00221	CbGeAlD
Bosutinib—EPHB3—brain—restless legs syndrome	0.000294	0.0022	CbGeAlD
Bosutinib—STK36—brain—restless legs syndrome	0.000294	0.0022	CbGeAlD
Bosutinib—AXL—nervous system—restless legs syndrome	0.000294	0.0022	CbGeAlD
Bosutinib—FYN—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000294	0.00345	CbGpPWpGaD
Bosutinib—MAP2K1—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000292	0.00343	CbGpPWpGaD
Bosutinib—EGFR—Syndecan-3-mediated signaling events—POMC—restless legs syndrome	0.000291	0.00342	CbGpPWpGaD
Bosutinib—TAOK3—spinal cord—restless legs syndrome	0.000291	0.00218	CbGeAlD
Bosutinib—MERTK—brain—restless legs syndrome	0.00029	0.00218	CbGeAlD
Bosutinib—SRC—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.00029	0.0034	CbGpPWpGaD
Bosutinib—MAP2K2—Insulin Signaling—MAP2K5—restless legs syndrome	0.000287	0.00337	CbGpPWpGaD
Bosutinib—SYK—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.000286	0.00335	CbGpPWpGaD
Bosutinib—RPS6KB1—central nervous system—restless legs syndrome	0.000286	0.00214	CbGeAlD
Bosutinib—MAP4K4—brain—restless legs syndrome	0.000285	0.00214	CbGeAlD
Bosutinib—MAP2K2—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000284	0.00333	CbGpPWpGaD
Bosutinib—FGR—central nervous system—restless legs syndrome	0.000284	0.00213	CbGeAlD
Bosutinib—SRC—spinal cord—restless legs syndrome	0.000283	0.00212	CbGeAlD
Bosutinib—NUAK2—brain—restless legs syndrome	0.000283	0.00212	CbGeAlD
Bosutinib—BCR—brain—restless legs syndrome	0.000283	0.00212	CbGeAlD
Bosutinib—AXL—central nervous system—restless legs syndrome	0.000283	0.00212	CbGeAlD
Bosutinib—MAP3K12—brain—restless legs syndrome	0.000281	0.00211	CbGeAlD
Bosutinib—PRKCQ—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.000281	0.00329	CbGpPWpGaD
Bosutinib—SRC—ErbB1 downstream signaling—MAP2K5—restless legs syndrome	0.000279	0.00327	CbGpPWpGaD
Bosutinib—MAP2K2—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000276	0.00324	CbGpPWpGaD
Bosutinib—MAP2K1—brain—restless legs syndrome	0.000275	0.00206	CbGeAlD
Bosutinib—STK35—brain—restless legs syndrome	0.000275	0.00206	CbGeAlD
Bosutinib—EPHA2—nervous system—restless legs syndrome	0.000275	0.00206	CbGeAlD
Bosutinib—FYN—nervous system—restless legs syndrome	0.000275	0.00206	CbGeAlD
Bosutinib—CSK—brain—restless legs syndrome	0.000273	0.00205	CbGeAlD
Bosutinib—CSNK1A1—brain—restless legs syndrome	0.000272	0.00204	CbGeAlD
Bosutinib—CSK—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.000271	0.00318	CbGpPWpGaD
Bosutinib—ABL1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.00027	0.00317	CbGpPWpGaD
Bosutinib—HCK—brain—restless legs syndrome	0.00027	0.00202	CbGeAlD
Bosutinib—CLK1—brain—restless legs syndrome	0.00027	0.00202	CbGeAlD
Bosutinib—PDGFRB—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000269	0.00316	CbGpPWpGaD
Bosutinib—MAP4K5—nervous system—restless legs syndrome	0.000269	0.00201	CbGeAlD
Bosutinib—MAP3K3—nervous system—restless legs syndrome	0.000269	0.00201	CbGeAlD
Bosutinib—MAP2K1—Insulin Signaling—MAP2K5—restless legs syndrome	0.000268	0.00315	CbGpPWpGaD
Bosutinib—ABL2—brain—restless legs syndrome	0.000268	0.00201	CbGeAlD
Bosutinib—MAP2K1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000266	0.00312	CbGpPWpGaD
Bosutinib—EPHA2—central nervous system—restless legs syndrome	0.000265	0.00199	CbGeAlD
Bosutinib—BMP2K—brain—restless legs syndrome	0.000265	0.00199	CbGeAlD
Bosutinib—CAMK2G—brain—restless legs syndrome	0.000265	0.00199	CbGeAlD
Bosutinib—FYN—central nervous system—restless legs syndrome	0.000265	0.00198	CbGeAlD
Bosutinib—ERBB3—Signaling by NGF—MAP2K5—restless legs syndrome	0.000263	0.00309	CbGpPWpGaD
Bosutinib—LRRK2—brain—restless legs syndrome	0.000263	0.00197	CbGeAlD
Bosutinib—EGFR—brain—restless legs syndrome	0.000262	0.00196	CbGeAlD
Bosutinib—PRKCQ—Corticotropin-releasing hormone—POMC—restless legs syndrome	0.00026	0.00306	CbGpPWpGaD
Bosutinib—MAP2K5—spinal cord—restless legs syndrome	0.00026	0.00195	CbGeAlD
Bosutinib—MAP3K3—central nervous system—restless legs syndrome	0.000259	0.00194	CbGeAlD
Bosutinib—MAP4K5—central nervous system—restless legs syndrome	0.000259	0.00194	CbGeAlD
Bosutinib—MAP2K1—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000258	0.00303	CbGpPWpGaD
Bosutinib—PTK2B—brain—restless legs syndrome	0.000256	0.00192	CbGeAlD
Bosutinib—CSF1R—spinal cord—restless legs syndrome	0.000254	0.00191	CbGeAlD
Bosutinib—CSNK1E—brain—restless legs syndrome	0.000252	0.00189	CbGeAlD
Bosutinib—MAP2K2—Focal Adhesion—MAP2K5—restless legs syndrome	0.00025	0.00293	CbGpPWpGaD
Bosutinib—SRC—Syndecan-3-mediated signaling events—POMC—restless legs syndrome	0.000248	0.00291	CbGpPWpGaD
Bosutinib—YES1—nervous system—restless legs syndrome	0.000248	0.00186	CbGeAlD
Bosutinib—SIK1—brain—restless legs syndrome	0.000248	0.00186	CbGeAlD
Bosutinib—IRAK4—brain—restless legs syndrome	0.000248	0.00186	CbGeAlD
Bosutinib—STK10—nervous system—restless legs syndrome	0.000246	0.00184	CbGeAlD
Bosutinib—EPHA4—brain—restless legs syndrome	0.000245	0.00184	CbGeAlD
Bosutinib—TAOK3—nervous system—restless legs syndrome	0.000245	0.00184	CbGeAlD
Bosutinib—PDGFRB—Focal Adhesion—MAP2K5—restless legs syndrome	0.000244	0.00286	CbGpPWpGaD
Bosutinib—ERBB3—brain—restless legs syndrome	0.000243	0.00182	CbGeAlD
Bosutinib—ULK3—brain—restless legs syndrome	0.000242	0.00182	CbGeAlD
Bosutinib—MAP2K2—brain—restless legs syndrome	0.000242	0.00182	CbGeAlD
Bosutinib—MAP3K2—brain—restless legs syndrome	0.000241	0.0018	CbGeAlD
Bosutinib—YES1—central nervous system—restless legs syndrome	0.000239	0.00179	CbGeAlD
Bosutinib—SRC—nervous system—restless legs syndrome	0.000239	0.00179	CbGeAlD
Bosutinib—MAP3K7—brain—restless legs syndrome	0.000238	0.00179	CbGeAlD
Bosutinib—STK10—central nervous system—restless legs syndrome	0.000237	0.00177	CbGeAlD
Bosutinib—TAOK3—central nervous system—restless legs syndrome	0.000236	0.00177	CbGeAlD
Bosutinib—TBK1—brain—restless legs syndrome	0.000236	0.00177	CbGeAlD
Bosutinib—PTK2—brain—restless legs syndrome	0.000236	0.00177	CbGeAlD
Bosutinib—FYN—Focal Adhesion—MAP2K5—restless legs syndrome	0.000235	0.00276	CbGpPWpGaD
Bosutinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000234	0.00275	CbGpPWpGaD
Bosutinib—MAP2K1—Focal Adhesion—MAP2K5—restless legs syndrome	0.000234	0.00275	CbGpPWpGaD
Bosutinib—IRAK1—brain—restless legs syndrome	0.000231	0.00173	CbGeAlD
Bosutinib—EGFR—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000231	0.00271	CbGpPWpGaD
Bosutinib—SRC—central nervous system—restless legs syndrome	0.00023	0.00172	CbGeAlD
Bosutinib—PDGFRB—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000229	0.00268	CbGpPWpGaD
Bosutinib—RPS6KB1—brain—restless legs syndrome	0.000227	0.0017	CbGeAlD
Bosutinib—PDGFRB—spinal cord—restless legs syndrome	0.000225	0.00169	CbGeAlD
Bosutinib—FGR—brain—restless legs syndrome	0.000225	0.00169	CbGeAlD
Bosutinib—AXL—brain—restless legs syndrome	0.000224	0.00168	CbGeAlD
Bosutinib—EGFR—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000224	0.00263	CbGpPWpGaD
Bosutinib—FYN—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00022	0.00259	CbGpPWpGaD
Bosutinib—MAP2K5—nervous system—restless legs syndrome	0.000219	0.00165	CbGeAlD
Bosutinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000219	0.00257	CbGpPWpGaD
Bosutinib—IRAK1—Signaling by NGF—MAP2K5—restless legs syndrome	0.000219	0.00257	CbGpPWpGaD
Bosutinib—SRC—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000216	0.00254	CbGpPWpGaD
Bosutinib—SLK—brain—restless legs syndrome	0.000216	0.00162	CbGeAlD
Bosutinib—EPHB4—brain—restless legs syndrome	0.000214	0.00161	CbGeAlD
Bosutinib—CSF1R—nervous system—restless legs syndrome	0.000214	0.00161	CbGeAlD
Bosutinib—MAP2K5—central nervous system—restless legs syndrome	0.000211	0.00158	CbGeAlD
Bosutinib—EPHA2—brain—restless legs syndrome	0.00021	0.00158	CbGeAlD
Bosutinib—FYN—brain—restless legs syndrome	0.00021	0.00157	CbGeAlD
Bosutinib—CSF1R—central nervous system—restless legs syndrome	0.000206	0.00155	CbGeAlD
Bosutinib—MAP3K3—brain—restless legs syndrome	0.000205	0.00154	CbGeAlD
Bosutinib—MAP4K5—brain—restless legs syndrome	0.000205	0.00154	CbGeAlD
Bosutinib—STK4—Signaling Pathways—MAP2K5—restless legs syndrome	0.000204	0.00239	CbGpPWpGaD
Bosutinib—EGFR—Focal Adhesion—MAP2K5—restless legs syndrome	0.000203	0.00239	CbGpPWpGaD
Bosutinib—ABL1—spinal cord—restless legs syndrome	0.000201	0.00151	CbGeAlD
Bosutinib—SRC—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000197	0.00231	CbGpPWpGaD
Bosutinib—EGFR—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00019	0.00224	CbGpPWpGaD
Bosutinib—PDGFRB—nervous system—restless legs syndrome	0.00019	0.00142	CbGeAlD
Bosutinib—YES1—brain—restless legs syndrome	0.00019	0.00142	CbGeAlD
Bosutinib—STK10—brain—restless legs syndrome	0.000188	0.00141	CbGeAlD
Bosutinib—WEE1—Hemostasis—TF—restless legs syndrome	0.000187	0.0022	CbGpPWpGaD
Bosutinib—TAOK3—brain—restless legs syndrome	0.000187	0.0014	CbGeAlD
Bosutinib—LCK—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000184	0.00215	CbGpPWpGaD
Bosutinib—PDGFRB—central nervous system—restless legs syndrome	0.000183	0.00137	CbGeAlD
Bosutinib—SRC—brain—restless legs syndrome	0.000182	0.00137	CbGeAlD
Bosutinib—MAP2K2—Signaling by NGF—MAP2K5—restless legs syndrome	0.00018	0.00212	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling by NGF—MAP2K5—restless legs syndrome	0.000176	0.00206	CbGpPWpGaD
Bosutinib—SRC—Focal Adhesion—MAP2K5—restless legs syndrome	0.000173	0.00203	CbGpPWpGaD
Bosutinib—STK3—Signaling Pathways—MAP2K5—restless legs syndrome	0.000173	0.00203	CbGpPWpGaD
Bosutinib—FYN—Signaling by NGF—MAP2K5—restless legs syndrome	0.00017	0.00199	CbGpPWpGaD
Bosutinib—ABL1—nervous system—restless legs syndrome	0.000169	0.00127	CbGeAlD
Bosutinib—MAP2K1—Signaling by NGF—MAP2K5—restless legs syndrome	0.000169	0.00198	CbGpPWpGaD
Bosutinib—MAP2K5—brain—restless legs syndrome	0.000168	0.00126	CbGeAlD
Bosutinib—CSF1R—brain—restless legs syndrome	0.000164	0.00123	CbGeAlD
Bosutinib—ABL1—central nervous system—restless legs syndrome	0.000163	0.00122	CbGeAlD
Bosutinib—SRC—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000162	0.00191	CbGpPWpGaD
Bosutinib—PTK2—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.000154	0.0018	CbGpPWpGaD
Bosutinib—SYK—Hemostasis—TF—restless legs syndrome	0.000147	0.00173	CbGpPWpGaD
Bosutinib—EGFR—Signaling by NGF—MAP2K5—restless legs syndrome	0.000146	0.00172	CbGpPWpGaD
Bosutinib—PDGFRB—brain—restless legs syndrome	0.000145	0.00109	CbGeAlD
Bosutinib—FER—Signaling Pathways—MAP2K5—restless legs syndrome	0.000145	0.0017	CbGpPWpGaD
Bosutinib—PRKCQ—Hemostasis—TF—restless legs syndrome	0.000145	0.0017	CbGpPWpGaD
Bosutinib—PTK2—Corticotropin-releasing hormone—POMC—restless legs syndrome	0.000143	0.00168	CbGpPWpGaD
Bosutinib—LCK—Signaling by NGF—MAP2K5—restless legs syndrome	0.000141	0.00166	CbGpPWpGaD
Bosutinib—CSK—Hemostasis—TF—restless legs syndrome	0.00014	0.00164	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—MAP2K5—restless legs syndrome	0.000138	0.00162	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—MAP2K5—restless legs syndrome	0.000131	0.00154	CbGpPWpGaD
Bosutinib—ABL1—brain—restless legs syndrome	0.000129	0.00097	CbGeAlD
Bosutinib—ABCB1—HIF-1-alpha transcription factor network—TF—restless legs syndrome	0.000128	0.0015	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—MAP2K5—restless legs syndrome	0.000126	0.00148	CbGpPWpGaD
Bosutinib—SRC—Signaling by NGF—MAP2K5—restless legs syndrome	0.000125	0.00147	CbGpPWpGaD
Bosutinib—CDK2—Hemostasis—TF—restless legs syndrome	0.000123	0.00144	CbGpPWpGaD
Bosutinib—LYN—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.000113	0.00133	CbGpPWpGaD
Bosutinib—FYN—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.000111	0.00131	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—MAP2K5—restless legs syndrome	0.00011	0.00129	CbGpPWpGaD
Bosutinib—MAP2K1—Corticotropin-releasing hormone—POMC—restless legs syndrome	0.000103	0.00121	CbGpPWpGaD
Bosutinib—FGR—Hemostasis—TF—restless legs syndrome	9.68e-05	0.00114	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—MAP2K5—restless legs syndrome	9.35e-05	0.0011	CbGpPWpGaD
Bosutinib—LCK—Platelet activation, signaling and aggregation—TF—restless legs syndrome	9.26e-05	0.00109	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—MAP2K5—restless legs syndrome	9.18e-05	0.00108	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—MAP2K5—restless legs syndrome	9.18e-05	0.00108	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—MAP2K5—restless legs syndrome	8.87e-05	0.00104	CbGpPWpGaD
Bosutinib—SRC—Platelet activation, signaling and aggregation—TF—restless legs syndrome	8.2e-05	0.000963	CbGpPWpGaD
Bosutinib—PTK2—Hemostasis—TF—restless legs syndrome	7.92e-05	0.00093	CbGpPWpGaD
Bosutinib—YES1—Hemostasis—TF—restless legs syndrome	7.81e-05	0.000917	CbGpPWpGaD
Bosutinib—CYP3A4—nervous system—restless legs syndrome	7.44e-05	0.000558	CbGeAlD
Bosutinib—CSNK1E—Signaling Pathways—MAP2K5—restless legs syndrome	7.42e-05	0.000871	CbGpPWpGaD
Bosutinib—CYP3A4—central nervous system—restless legs syndrome	7.16e-05	0.000537	CbGeAlD
Bosutinib—ERBB4—Signaling Pathways—MAP2K5—restless legs syndrome	6.41e-05	0.000752	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—MAP2K5—restless legs syndrome	6.32e-05	0.000742	CbGpPWpGaD
Bosutinib—ABCB1—spinal cord—restless legs syndrome	6.25e-05	0.000468	CbGeAlD
Bosutinib—ROCK1—Signaling Pathways—MAP2K5—restless legs syndrome	6.09e-05	0.000714	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—MAP2K5—restless legs syndrome	5.86e-05	0.000688	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	5.85e-05	0.000687	CbGpPWpGaD
Bosutinib—LYN—Hemostasis—TF—restless legs syndrome	5.83e-05	0.000684	CbGpPWpGaD
Bosutinib—ABL1—Hemostasis—TF—restless legs syndrome	5.8e-05	0.000681	CbGpPWpGaD
Bosutinib—FYN—Hemostasis—TF—restless legs syndrome	5.74e-05	0.000673	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—MAP2K5—restless legs syndrome	5.65e-05	0.000663	CbGpPWpGaD
Bosutinib—ABCB1—nervous system—restless legs syndrome	5.26e-05	0.000395	CbGeAlD
Bosutinib—ABCB1—central nervous system—restless legs syndrome	5.07e-05	0.00038	CbGeAlD
Bosutinib—PTK2—Signaling Pathways—MAP2K5—restless legs syndrome	5.03e-05	0.00059	CbGpPWpGaD
Bosutinib—STK4—Signaling Pathways—POMC—restless legs syndrome	5.01e-05	0.000588	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—MAP2K5—restless legs syndrome	4.96e-05	0.000582	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—TF—restless legs syndrome	4.78e-05	0.000561	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—MAP2K5—restless legs syndrome	4.71e-05	0.000552	CbGpPWpGaD
Bosutinib—PHKG1—Metabolism—POMC—restless legs syndrome	4.54e-05	0.000533	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—MAP2K5—restless legs syndrome	4.43e-05	0.00052	CbGpPWpGaD
Bosutinib—STK3—Signaling Pathways—POMC—restless legs syndrome	4.26e-05	0.0005	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—TF—restless legs syndrome	4.23e-05	0.000496	CbGpPWpGaD
Bosutinib—PRKCQ—GPCR downstream signaling—POMC—restless legs syndrome	4.21e-05	0.000494	CbGpPWpGaD
Bosutinib—ABCB1—brain—restless legs syndrome	4.02e-05	0.000302	CbGeAlD
Bosutinib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	3.91e-05	0.000459	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MAP2K5—restless legs syndrome	3.87e-05	0.000454	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling by GPCR—POMC—restless legs syndrome	3.82e-05	0.000449	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MAP2K5—restless legs syndrome	3.78e-05	0.000443	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MAP2K5—restless legs syndrome	3.7e-05	0.000434	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MAP2K5—restless legs syndrome	3.64e-05	0.000427	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MAP2K5—restless legs syndrome	3.62e-05	0.000425	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—POMC—restless legs syndrome	3.57e-05	0.000419	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—POMC—restless legs syndrome	3.38e-05	0.000397	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—POMC—restless legs syndrome	3.23e-05	0.000379	CbGpPWpGaD
Bosutinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	3.17e-05	0.000372	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MAP2K5—restless legs syndrome	3.15e-05	0.000369	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—POMC—restless legs syndrome	3.1e-05	0.000363	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MAP2K5—restless legs syndrome	3.03e-05	0.000356	CbGpPWpGaD
Bosutinib—ROCK1—GPCR downstream signaling—POMC—restless legs syndrome	2.79e-05	0.000328	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—POMC—restless legs syndrome	2.71e-05	0.000318	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MAP2K5—restless legs syndrome	2.68e-05	0.000315	CbGpPWpGaD
Bosutinib—ROCK1—Signaling by GPCR—POMC—restless legs syndrome	2.53e-05	0.000297	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—POMC—restless legs syndrome	2.3e-05	0.00027	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—POMC—restless legs syndrome	2.26e-05	0.000265	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—POMC—restless legs syndrome	2.26e-05	0.000265	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—POMC—restless legs syndrome	2.18e-05	0.000256	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—TF—restless legs syndrome	2.17e-05	0.000254	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—POMC—restless legs syndrome	1.82e-05	0.000214	CbGpPWpGaD
Bosutinib—CYP3A4—Biological oxidations—POMC—restless legs syndrome	1.68e-05	0.000198	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—POMC—restless legs syndrome	1.61e-05	0.000189	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—POMC—restless legs syndrome	1.58e-05	0.000185	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—POMC—restless legs syndrome	1.55e-05	0.000182	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—POMC—restless legs syndrome	1.51e-05	0.000177	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—POMC—restless legs syndrome	1.5e-05	0.000176	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—POMC—restless legs syndrome	1.44e-05	0.000169	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—POMC—restless legs syndrome	1.44e-05	0.000169	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—POMC—restless legs syndrome	1.39e-05	0.000163	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—POMC—restless legs syndrome	1.31e-05	0.000154	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—POMC—restless legs syndrome	1.24e-05	0.000145	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—POMC—restless legs syndrome	1.22e-05	0.000143	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—POMC—restless legs syndrome	1.16e-05	0.000136	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—POMC—restless legs syndrome	1.09e-05	0.000128	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—POMC—restless legs syndrome	9.52e-06	0.000112	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—POMC—restless legs syndrome	9.29e-06	0.000109	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—POMC—restless legs syndrome	9.1e-06	0.000107	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—POMC—restless legs syndrome	8.96e-06	0.000105	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—POMC—restless legs syndrome	8.91e-06	0.000105	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—POMC—restless legs syndrome	7.74e-06	9.08e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—POMC—restless legs syndrome	7.46e-06	8.75e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—POMC—restless legs syndrome	6.6e-06	7.75e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—POMC—restless legs syndrome	4.67e-06	5.48e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—POMC—restless legs syndrome	2.88e-06	3.38e-05	CbGpPWpGaD
